Close Menu

NEW YORK (GenomeWeb) – Enzo Biochem said today that it has reached a settlement with Thermo Fisher Scientific's Life Technologies business on two patent infringement lawsuits.

Thermo Fisher will pay Enzo $35 million to settle the claims Enzo filed in Delaware Federal District Court in 2012. Enzo claimed Life Tech infringed on two patents — No. 6,992,180, entitled Oligo- or Polynucleotides Comprising Phosphate Moiety Labeled Nucleotides, and No. 7,064,197, entitled System, Array and Non-Porous Solid Support Comprising Fixed or Immobilized Nucleic Acids.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.